|
J Biol Chem, Vol. 273, Issue 27, 16880-16889, July 3, 1998
NF-Y Organizes the -Globin CCAAT Boxes Region*
Chiara
Liberati,
Antonella
Ronchi ,
Patricia
Lievens,
Sergio
Ottolenghi§, and
Roberto
Mantovani§
From the Dipartimento di Genetica e di Biologia dei Microrganismi,
Università di Milano, Via Celoria 26, 20133 Milano, Italy
 |
ABSTRACT |
The CCAAT-binding activator NF-Y is formed by
three evolutionary conserved subunits, two of which contain putative
histone-like domains. We investigated NF-Y binding to all CCAAT boxes
of globin promoters in direct binding, competition, and supershift
electrophoretic mobility shift assay; we found that the , , and
proximal CCAAT boxes of human and the prosimian Galago bind avidly,
and distal CCAAT boxes have intermediate affinity, whereas the and sequences bind NF-Y very poorly. We developed an efficient
in vitro transcription system from erythroid K562 cells and
established that both the distal and the proximal CCAAT boxes are
important for optimal -globin promoter activity. Surprisingly, NF-Y
binding to a mutated distal CCAAT box (a C to T at position 114) is
remarkably increased upon occupancy of the high affinity proximal
element, located 27 base pairs away. Shortening the distance between
the two CCAAT boxes progressively prevents simultaneous CCAAT binding, indicating that NF-Y interacts in a mutually exclusive way with CCAAT
boxes closer than 24 base pairs apart. A combination of circular
permutation and phasing analysis proved that (i) NF-Y-induced angles of
the two -globin CCAAT boxes have similar amplitudes; (ii) occupancy
of the two CCAAT boxes leads to compensatory distortions; (iii) the two
NF-Y bends are spatially oriented with combined twisting angles of
about 100°. Interestingly, such distortions are reminiscent of core
histone-DNA interactions. We conclude that NF-Y binding imposes a high
level of functionally important coordinate organization to the
-globin promoter.
 |
INTRODUCTION |
The CCAAT box is a widespread regulatory sequence found in
promoters and enhancers of several genes (1), whose functional importance has been well established in different systems (2-12). NF-Y
(also termed CBF) has an almost absolute requirement for these five
nucleotides and a strong preference for additional flanking sequences
(13, 14). Based on supershift experiments with anti-NF-Y antibodies, on
competition analysis with the original Ea Y box
oligo,1 or on the heteromeric
nature of the DNA-binding complex, NF-Y has been identified as the
CCAAT box activator in over 100 promoters (7-11, 14, 15). The CCAAT
consensus derived statistically by Bucher (1) (RRCCAAT(C/G)(A/G)) fits
well with the optimal NF-Y-binding site.
NF-Y is a ubiquitous heteromeric protein composed of three subunits,
NF-YA, NF-YB, and NF-YC, all necessary for DNA binding (16, 17). The
cloning of NF-Y genes from several species including yeast, maize,
lamprey, and sea urchin, evidenced highly conserved domains (16-22).
The NF-YA homology domain can be divided into subunit association and
DNA-contacting subdomains (20). The N-terminal contains a hydrophobic
and Gln-rich activation surface (18). The NF-YC gene has been recently
cloned and is specular with respect to NF-YA, since the homology domain
is at the N terminus, whereas the C-terminal 180 amino acids are rich
in glutamines and hydrophobic residues. NF-YB and NF-YC tightly
interact with each other, and their association is a prerequisite for
NF-YA binding and sequence-specific DNA interactions (16, 22). Both the
NF-YB- and NF-YC-conserved domains contain putative histone fold
motifs. This motif, common to all core histones, is responsible for the
formation of the histone octamer (24) and is composed of three
-helices, separated by short loops/strand regions, enabling histones
to dimerize with companion subunits (24, 25). Recent experiments on the
yeast HAP3 (26), NF-YB/CBF-A (27), and NF-YC/CBF-C (28) indicate that
this 65 amino acid long motif is necessary for subunit interactions and
DNA binding. NF-Y has additional interesting features as follows: (i)
CCAAT boxes are not able to activate alone even if multimerized,
but they increase the activity of neighboring enhancer motifs. (ii)
NF-Y appears to increase the affinity of transcription factors for
their target sequence (29). However, the exact mechanisms of
transcriptional activation by NF-Y are still elusive.
Globin genes are transcribed in a tissue-specific and developmentally
regulated manner by means of various regulatory elements in their
clusters (30). In addition to the locus control regions which have been
characterized in transgenic mice, the promoters of each globin gene
contain sequences that usually impart tissue-specific control in
transfection experiments. Several lines of reasoning point to CCAAT
sequences as important elements in globin gene expression as follows:
(i) they are present in all globin promoters; (ii) they have been
remarkably conserved in different species at a fixed distance from the
cap site; (iii) genomic footprinting of all globin promoters in
erythroid cells showed invariable protection of CCAAT sequences
in vivo, indicating binding of activators (31); (iv) the
functional importance has been documented in the -, -, -, and
-globin promoters (2-5, 15); (v) the -globin duplicated CCAAT
boxes are the target of mutations affecting developmental silencing of
-globin expression in adult life. In particular, strong genetic
evidence suggests that point mutations in the CCAAT box region are
causative of the HPFH syndromes, characterized by increased fetal
globin levels in adults (32-37).
Several studies investigated factors binding to CCAAT; CDP, NFE3, and
c/EBP appear to recognize different globin promoters (3, 32-36). One
CCAAT-binding protein, -CP1, was purified to homogeneity using an
-globin CCAAT box affinity column and found to be a trimeric factor
most likely identical to NF-Y (15). Moreover, competition and
supershift EMSA experiments performed with nuclear extracts determined
that a CCAAT binding activity similar to NF-Y (termed CP1 in the globin
field) binds to the -globin promoters (32, 33). However,
identification of CCAAT binding activities in other promoters is less
certain; therefore, we wished to definitely determine which of the
globin CCAAT boxes represents a bona fide NF-Y-binding site and
establish a hierarchy of affinities. We then focused our attention on
the highly regulated -globin duplicated CCAAT box region. Because of
the histone-like nature of NF-Y and its ability to distort DNA, we
examined the possibility that NF-Y organizes this region.
 |
MATERIALS AND METHODS |
Plasmid Constructions--
The starting plasmid for the circular
permutation assays was pBend2 (14). The proximal and distal CCAAT box
oligos described in Table I were inserted by blunt end ligation into
the XbaI site. The double CCAAT and the phasing analysis
oligos were also cloned into the XbaI site.
Plasmids for in vitro transcription (pAG1 and mutants
thereof) were obtained by inserting the -globin promoter ( 299 to
+35) into the PA101 vector (38). The SV40 promoter was excised by cutting with HindIII and BamHI, filling in with
Klenow, and religating. Mutants were derived by polymerase chain
reaction before cloning into PA101; pAG2 contains mutations in the
distal CCAAT 3' region ( 109 AGCC to GACT) that render it identical to
the -globin CCAAT box. pAG3 has a mutation at position 86 of the
proximal CCAAT (A to C). pAG4 contains a 13-bp deletion of the distal
CCAAT (from 122 to 109). pAG5 harbors both the distal CCAAT-
swap of pAG2 and the point mutation ( 86 A to C) of pAG3 in the
proximal CCAAT. pAG6 contains a triple mutation (CCAAT to TCTAG) in
both the distal and the proximal CCAAT boxes. All constructs were
checked by sequencing.
Electrophoretic Mobility Shift Assay (EMSA)--
Labeled
oligonucleotides (10,000 cpm) containing the different globin CCAAT
boxes were incubated with K562 nuclear extracts (5 µg) for 30 min at
25 °C. Binding reactions for NF-Y were performed incubating labeled
oligonucleotides for 20 min at 20 °C, in a buffer containing 5%
glycerol, 50 mM NaCl, 20 mM Tris, pH 7.5, 0.5 mM EDTA, 5 mM MgCl2, and 1 mM dithiothreitol, and run in 4% polyacrylamide gels
(acrylamide/bis-acrylamide ratio of 29:1) at 4 °C. Supershift
experiments were performed as described in Ref. 12.
Competition experiments were performed following two different
incubation procedures as described in Fig. 6: increasing concentrations (1, 3, 10, and 25 ng) of cold competitors were incubated either before
addition of the labeled oligos (6000 cpm) or after 10 min of incubation
of NF-Y with the probe.
Recombinant NF-YA9 and purified NF-YB/C were prepared as in Refs. 22
and 39. For circular permutation assays, NF-Y was incubated with
end-labeled fragments generated by cuts with different enzymes (2000 cpm in each reaction). Fragments generated by the central
XhoI digestions were used for the phasing analysis.
Calculations of Bending Angles--
Location of the points of
flexure and amplitudes of the bending angles were described previously
(14, 40). Briefly, the mobilities of the NF-Y-DNA complexes were
normalized to the mobilities of the corresponding free DNA fragments;
bending angles were calculated considering the ratio between the
fastest and the slowest migrating complexes in EMSA, according to the
formula mM/mE = cos
a/2, where mM is the relative mobility of
the complex exactly in the middle, mE is the
relative mobility of the complex at the end of the fragment, and
a is the angle of deviation. To determine bending centers,
the normalized mobility of each NF-Y-DNA complex was plotted as a
function of the distance between the center of the CCAAT sequence and
the end of the DNA fragment; the bend was determined as the position at
which the NF-Y-DNA complex was at a minimum.
In the phasing analysis, the mobility of the upper bands of the +3,
3, and 5 oligos was normalized for the mobility of the lower
bands and plotted against that of the wt fragment. The best fitting
equation and the R2 value were calculated by
means of Microsoft Excel 7.
In Vitro Transcription--
Preparation of transcriptionally
competent K562 nuclear extracts and in vitro transcription
reactions were detailed in Ref. 38. Two independent CsCl plasmid
preparations of the pAG vectors were used in different sets of
experiments.
 |
RESULTS |
NF-Y Binds to CCAAT Boxes of All Globin Promoters--
To
determine which of the globin CCAAT boxes is recognized by NF-Y, we
labeled oligonucleotides (see Table I)
for EMSA experiments with nuclear extracts, challenging the resulting
complexes with anti-NF-YB- and anti-NF-YA-purified antibodies (12).
Bands of different mobilities and intensities are generated with all
oligos (Fig. 1), with the (lanes 4-6), (lanes 8-10), h P (human proximal, lanes 16-18), g P (prosimian Galago
crassicaudatus proximal, see Ref. 36, lanes
28-30), h D (human distal, lanes 20-22) and
g D (G. crassicaudatus distal, lanes
32-34), one predominant shifted band is visible; these complexes
are supershifted by specific anti-YB and anti-YAc antibodies (12). In
each case we ran parallel migrations of the Y box oligo incubated with
recombinant NF-YA and purified NF-YB/NF-YC; as shown in Fig. 1, the
bands have electrophoretic behaviors identical to the endogenous K562 bands shifted by the anti-NF-Y antibodies. On the other hand, with the
and CCAAT multiple bands are visualized (lanes
12-14 and 24-26); for the a weak band comigrating
with NF-Y and supershifted by the antibodies is observed, and for the
the four major bands detected have different mobilities compared
with the Y/NF-Y band, and no supershift is evident. These data show
that NF-Y binding is readily visualized on all globin CCAAT boxes and
is the most prominent binding protein, with the exception of and
, which show a much higher affinity for proteins unrelated to
NF-Y.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 1.
EMSA analysis of nuclear proteins binding to
globin CCAAT boxes. The labeled oligos indicated above are
incubated with K562 nuclear extracts (5 µg) in the absence
(lanes 1, 4, 8, 12, 16, 20, 24, 28, and 32) or in
the presence of purified anti-YAC or anti-YB antibodies. Purified NF-Y
was run in parallel with the MHC Ea Y box oligo (lanes 7, 11, 15, 19, 23, 27, 31, and 35). Asterisks refer to
the NF-E3 band visible on the -h D and
g P CCAAT boxes, as described previously (32, 36)
|
|
To determine the relative affinity of NF-Y for each of the globin CCAAT
boxes, we then incubated purified NF-YB/NF-YC and recombinant NF-YA
with the different labeled oligos in the absence (Fig.
2, see lane 1) or in the
presence of 20- and 100-fold excess of cold competing
oligos containing the different CCAAT boxes examined above. Results are
shown in lanes 2-19. Y box binding is efficiently competed
only by , whereas and the P, both from human and
Galago, have a somewhat lower affinity (see quantification of the data in Fig. 2B). All these CCAAT boxes clearly have
a higher affinity in cross-competitions than and the very low affinity . Note that the complex generated with the - and
-globin CCAAT boxes is visible only after prolonged exposures (3 and
7 days, respectively, in the experiment shown). In general, all data
are consistent with the fact that the better binders in direct EMSA are
also the most avid competitors. Cross-competition experiments establish
that the relative affinity of NF-Y for the different CCAAT boxes varies
profoundly by more than 2 orders of magnitude, ranging from very high
( and Y) to high ( , h P, and g P) to medium (g D) to low
( and ).

View larger version (66K):
[in this window]
[in a new window]

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 2.
A, cross-competition analysis of globin
CCAAT oligos. The indicated labeled oligos were incubated with purified
NF-Y in the absence (lanes 1) or presence of a 20- (even numbers) or a 100-fold (uneven numbers)
molar excess of the competing oligos (lanes 2-19). For the
and oligos, long exposures of 60 h and 7 days,
respectively, were necessary to visualize the NF-Y bands. B,
quantification of the data in A were obtained by
densitometric scanning of the gels.
|
|
Both -Globin CCAAT Boxes Contribute to Promoter Activity in
Vitro--
We next focused our attention on the developmentally
regulated -globin promoter. We fused the minimal tissue-specific
-globin promoter ( 299 to +35) to a rabbit -globin reporter gene
(plasmid pAG1) and generated mutants in the proximal or in the distal
CCAAT boxes (see scheme in Fig.
3A). The wt and mutated
constructs were tested in a functional in vitro assay with
transcriptionally competent erythroid K562 extracts. RNA was purified
and hybridized to a single-stranded end-labeled DNA probe; subsequent
S1 mapping allowed the determination of qualitative and quantitative
changes in the transcription rate. As an internal control we added a
plasmid containing the adenovirus major late promoter TATA box devoid of any activating sequences and fused to the same reporter gene. Fig.
3B shows that our system efficiently transcribes the
-globin promoter and faithfully reproduces the correct start site
used in vivo. We tested the different mutants: alteration of
the proximal CCAAT box or destruction of the distal by a 13-base pair
deletion (pAG3 and pAG4) decreases transcription 3-4-fold (Fig.
3C, lanes 3 and 4). Swapping the weak -globin
CCAAT box into the distal CCAAT box position partially restores
transcription when the proximal CCAAT is mutated, while having minor
effects when the proximal CCAAT is intact (pAG2 and pAG5, respectively;
Fig. 3C, lanes 1, 2 and 5). A mutant promoter
containing mutations in both CCAAT boxes (pAG6) was also compared with
wt pAG1 and resulted in the lowest transcriptional rate (6-fold down,
compare Fig. 3C, lanes 6 and 7). Note that the
signals in Fig. 3C result from a 4-h exposure. These data
indicate that both CCAAT elements contribute to the optimal promoter
activity. However, other important activators are probably operating,
since mutations in the CCAAT boxes do not abolish transcription
completely.

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 3.
In vitro transcription analysis of the
-globin promoter. A, a scheme representing the different
constructs used is depicted. All contained the -globin promoter
( 299/+35) fused to a rabbit -globin reporter. B,
mapping of -globin promoter-driven RNA by S1 analysis. In
vitro transcriptions with 100, 200, and 400 ng of pAG1 plasmid
were run in parallel with a sequencing reaction, to spot the
transcriptional start site in our in vitro system. The
signal corresponding to the probe is indicated. C, analysis
of CCAAT box -globin mutants. 200 ng of each plasmid and 4 µl of
transcription extract (40 µg) was used for in vitro
transcriptions, together with 50 ng of the pAL5 internal control,
generating the correct -globin +1 signal and the shorter -globin
signal. Given 100 in arbitrary units the activity of pAG1 and pAG2 was
60, pAG3 was 33, pAG4 was 26, pAG5 was 24, and pAG6 was 16.
|
|
Binding of NF-Y to the -Globin Double CCAAT Boxes
Region--
By having shown that both -globin CCAAT boxes bind NF-Y
and are important for in vitro promoter activity, we
investigated their interplay; we labeled a long oligo encompassing the
two CCAAT boxes, incubating increasing concentrations of recombinant NF-Y, containing wt NF-YA and NF-YB and the homology domain of NF-YC.
Fig. 4 shows that two bands of different
electrophoretic mobility are generated (lanes 1-4); to
ascertain whether the slow migrating complex corresponds to DNA
fragments bound by two NF-Y molecules, we used fragments mutated in the
distal CCAAT (C 114), in the proximal CCAAT (the
corresponding C to T mutation at 87), or in both. We have
deliberately chosen this mutation because genetic evidence strongly
associates it with HPFH syndromes in humans (34). Mutations in such
position are known to essentially abolish NF-Y binding to all CCAAT
boxes tested so far, including the -globin (13-15,
40).2 The faster complex is
only modestly affected by mutations in the distal CCAAT; the slower
complex is greatly diminished in the 87 CCAAT mutant and in the
double mutant (compare lanes 4, 12 and 16).
Surprisingly, the 114 mutant exhibited a considerable level of the
upper complex (compare lanes 4 and 8 and see the calculated ratios in Fig. 4B). With the double mutant, both
the slower and the faster complexes were also crippled (lanes
13-16). These data suggest that the faster band corresponds to
NF-Y binding to either the proximal or the distal site, whereas the
upper one results from double occupancy of the two CCAAT boxes.
Interestingly, consistent with the cross-competition experiments,
binding of NF-Y to the proximal CCAAT is predominant and compensates
for a crippling mutation in the distal CCAAT, whereas the reverse is
not true.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 4.
A, EMSA analysis of the double CCAAT box
-globin oligos. Dose-response of NF-Y with the wild type
(lanes 1-4, 0.1, 0.3, 1, and 5 ng) or oligos with mutations
(C to T in the second C of CCAAT) in the distal (lanes
5-8), proximal (lanes 9-12), or both CCAAT boxes. The
bands corresponding to single and double occupation of the CCAAT boxes
are indicated. B, quantification of the experiments in
A. The upper/lower complex ratios are indicated above each
mutant, except for DM, in which the upper complex was too weak to be
quantitated. , upper band; , lower band.
|
|
To better understand the mechanisms leading to double occupancy and
rule out the alternative explanation of the data in Fig. 4, namely that
the upper band is due to formation of an NF-Y dimer on single CCAAT
boxes, we rotationally moved the position of the two CCAAT by
introducing short deletions of 3, 5, and 8 base pairs between them.
Dose-response experiments were performed with labeled oligos; deletion
of three nucleotides has relatively little effect on double binding,
whereas a drop is observed with the 5 and even more with the 8
(Fig. 5, lanes 9-16); a 11
deletion was also tested and showed essentially no upper complex (not
shown). Thus, changing the rotational position of the two elements does not seem to increase double occupancy; rather, shortening the distance
between CCAAT boxes by less than 24 base pairs progressively inhibits
upper complex formation, while having no effect on the lower complex.
From this set of EMSA we conclude that the upper complex is indeed due
to simultaneous binding of NF-Y to the two CCAAT sequences.

View larger version (70K):
[in this window]
[in a new window]
|
Fig. 5.
EMSA analysis of short deletions between the
CCAAT boxes. Dose-response of NF-YA/NF-YB/NF-YC5 was performed
with either the wt oligo (lanes 1-4, 0.1, 0.3, 1 and 5 ng),
or with oligos containing deletions of 3 (lanes 5-8), 5 (lanes 9-12) and 8 (lanes 13-16) nucleotides in
the region between the CCAAT boxes.
|
|
We then wanted to verify whether NF-Y binding to the two sites is
cooperative. To this aim, we employed two incubation procedures outlined in Fig. 6, A and
B and C and D; increasing
concentrations of cold high affinity Y box competitor were incubated
either before addition of the labeled oligos, to prevent formation of
NF-Y-CCAAT complexes (panels A and B), or after
NF-Y-CCAAT binding (C and D). Results of the
preincubation experiments on all labeled oligos showed that double NF-Y
binding is decreased with equivalent efficiency compared with the
single occupancy band (Fig. 6, A and B, lanes 1-5 and 11-15 and quantification in 6E).
Parallel competitions performed with a mutated Y box cold oligo caused
no decrease in either NF-Y bands (Fig. 6, A and B,
lanes 6-10 and 16-20). However, the reverse order of
addition gave different indications. For 3 and 8, the decrease of
the upper band paralleled that of the lower complexes (Fig. 6,
C and D, lanes 11-15); on the 5 and, to a
much lesser extent, the wt oligos, the double occupancy band was more
resistant to competition than the single CCAAT-NF-Y (Fig. 6,
C and D, lanes 1-5; see 6E). The
latter result tends to suggest some form of cooperative behavior among
the two NF-Y molecules on the 5 CCAAT boxes and some interplay in
the wt. However, upon turning the reciprocal rotational positions of
the two CCAAT sequences by 80/100°, as in the 3 and 8, this
effect is not observed.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 6.
EMSA competition analysis on oligos with
CCAAT deletions. A, a 5-, 20-, 100-, and 500-fold molar
excess of competing wt (lanes 2-5 and 12-15) or
mutated Y box oligos (lanes 7-10 and 17-20)
were incubated with NF-YA/NF-YB/NF-YC5 (5 ng) before addition of the wt
and 3 labeled oligos (see scheme). B, same preincubation
as in A, except that labeled 5 and 8 oligos were used.
C, same as A except that the labeled wt and 3
oligos were first incubated with NF-YA/NF-YB/NF-YC5 (22) and then
challenged with the competing oligos (see scheme). D, same
as B, except that the same order of addition as in
C was used. For the 5 and 8 experiments a 10-fold
higher amount of NF-Y was necessary to visualize the upper NF-Y bands.
E, quantification of the data in
A-D.
|
|
NF-Y Induces Bending of -Globin CCAAT Boxes--
We have
recently shown that NF-Y is able to induce distortions in the double
helix, with angles that vary depending on the surrounding sequences
(14). By using the circular permutation assay we checked the degree of
distortion of the proximal and distal CCAAT boxes separately. We cloned
the two oligos of identical length in the pBend2 vector (14); we then
cut with different enzymes so that the CCAAT boxes were at different
distances from the extremities of the fragments, and we performed EMSA
with NF-Y. To calculate precisely the angles, we maximized the
differences in mobilities of the protein-DNA complexes, using the small
NF-YA9 mutant and purified endogenous NF-YB/NF-YC. We have shown that such combination does not alter significantly the distortion angles of
four NF-Y sites (14). Clear indication that NF-Y induces distortions on
both -globin CCAAT boxes was evident from the different
electrophoretic mobilities of the fragments (Fig.
7). Calculations of the angles gave
similar results for both sites, and the values, 66° and 72° for
distal and proximal, respectively, are similar to those observed for
the murine sarcoma virus and -globin and slightly lower than for the
Ea Y box and HSP70 NF-Y-binding sites. As expected, the flexures are
indeed centered on the CCAAT sequences (Ref. 14 and data not
shown).

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 7.
Circular permutation assay of NF-Y CCAAT
complexes. The pBend2 -CCAAT plasmids were digested with the
indicated enzymes, generating the fragments outlined in the underlying
cartoon. They were incubated with NF-YA9/NF-YB/NF-YC (14). Lanes
1-5, proximal CCAAT; lanes 6-10, distal CCAAT;
lanes 11-15, double CCAAT.
|
|
To verify the effect of two bound NF-Y molecules on the overall
distortion, we then repeated the circular permutation experiments with
the long -globin oligo (Fig. 7). As expected, two bands are visible
in EMSA. (i) The lower corresponds to occupancy of either the distal or
the proximal CCAAT and is therefore a mixture of proximal and distal
NF-Y binding. The arch formed by these bands is very similar to the one
observed in circular permutation assays with the single CCAAT. Note,
however, that in some of the lateral fragments the shifted bands are
rather wide; since the distances from the extremities of the proximal
versus the distal CCAAT are different, we do expect to see
slightly altered electrophoretic behaviors. (ii) The upper complex
mobilities are much more similar, with a calculated overall angle of
45°, suggesting compensation; much bigger differences between the
fragments would have been scored had NF-Y bending angles been additive.
Nonetheless, despite the presence of the two sites on opposite sides of
the double helix (they are separated by 27 bp, hence 2.5 helical
turns), a perfect straightening of the helix is not observed, as judged by this circular permutation EMSA, as one might have expected considering that the amplitudes of the two angles are nearly
identical.
Phasing Analysis of CCAAT Boxes--
To verify whether NF-Y
induces directed bends, as suggested by the previous experiment, and to
seek further information about the relative distortions of the CCAAT
region, we performed phasing analysis. This assay is usually tackled
with appropriate vectors containing a fixed angle of known curvature,
obtained exploiting the distortions caused by short AT-rich sequences
spaced by one turn of the helix (Ref. 40 and references therein).
Having fixed one angle, the binding site is rotationally moved on
different sides of the double helix, by increasing the distance from
the fixed angle, taking into account that one turn corresponds to 10.5 base pairs. The relative mobilities of the protein-bound complexes give
clues about the orientation of the angles. Rather than adopting this
strategy, which would give information about one isolated CCAAT, we
took advantage of the two -globin-binding sites with their
previously calculated distortions. We cloned in pBend2 the 3, 5,
8 oligos, and a +3 oligo, in which we added 3 bp between the two
CCAAT. Cutting the resulting plasmids with any of the enzymes generates
nearly identical fragments with NF-Y-binding sites rotationally
displaced with respect to the wt situation. EMSA analysis of the
central XhoI fragments is shown in Fig.
8, and comparable amounts of protein
generated the single occupancy band with identical electrophoretic
mobility for all fragments. The double occupancy band is visible with
the +3, wt, and 3 fragments, with the 5 only after prolonged
exposures, and is absent in the 8. The mobilities of the latter
bands are different, a clear indication that indeed the DNA is oriented
upon NF-Y binding (40). The slowest fragment should be the one in which
the two bends are in phase with respect to the helical turn of DNA,
whereas the fastest is the one in which the two bends are facing
opposite sides and counteract each other; the +3, in which the two
CCAAT boxes are only 1.5 bp away from perfect alignment on the same side of the helix, is the slowest, and the 3 and 5 are the
fastest. This is consistent with overall distortion angles of about
100° among the two CCAAT in the wt configuration (see Fig.
9). These results are indeed confirmed by
experiments with a "mini" NF-Y protein (22) that is able to
generate double bands in the 8 as well, which give a phasing
"period" of about 8 bp, corresponding to a rotation of about
100°.3

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 8.
Phasing analysis of NF-Y binding to the
double CCAAT box. The wt, +3, 3, 5, and 8 pBend2 vectors
were digested with XhoI and the fragments incubated with
NF-Y9/NF-YB/NF-YC. The band corresponding to double occupancy in the
5 was visible after prolonged exposures. The mobility of the upper
bands of the +3, 3, and 5 was plotted against that of the wt
fragment as indicated in the underlying scheme.
|
|

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 9.
The promoter targets of NF-Y in the globin
clusters and the NF-Y-induced distortions in the -globin CCAAT box
region.
|
|
 |
DISCUSSION |
In this study we undertook a systematic analysis of NF-Y binding
to the CCAAT boxes of globin gene promoters and established that most,
but not all, contain bona fide high affinity sites. We focused then on
the human -globin, and we developed an efficient in vitro
functional assay with K562 extracts and provided for the first time
evidence that both CCAAT boxes add to the overall level of expression.
NF-Y binds better to the proximal than to the distal site, and DNA
binding is neither cooperative nor mutually exclusive. The bending
angles of the isolated CCAAT boxes are similar, and double binding
induces compensatory alterations; the combined twisting angles are
about 100°.
NF-Y and the Globin CCAAT Boxes--
Previous experiments with
nuclear extracts identified several proteins binding to the CCAAT boxes
of various globin promoters. CDP binds to the duplicated -globin
CCAAT box region (32, 33), NF-E3 to the distal CCAAT box and to the
box (32, 36), and c/EBP to the CCAAT (3). The CCAAT box
region is bound by a number of factors (36). Binding of NF-Y has been
more than suspected; the -globin CCAAT box has been shown to
recognize a multimeric factor ( -CP1) which by several criteria is
NF-Y (15). The CCAAT boxes were also shown to be cross-competed by
the Ea Y box (32, 33). By performing a systematic EMSA analysis on all
globin CCAAT boxes with NF-Y, we found that the , , and proximal
CCAAT bind NF-Y efficiently, the distal CCAAT well, whereas the
affinity for and is so low that we consider it unlikely that
they are in vivo targets for NF-Y. A good binding site for
NF-Y requires two additional conserved nucleotides at the 5' and three
at the 3' (13, 41). As in all high affinity sites, two purines are
present in all globin sites at the 5' end, indicating that sequences at
the 3' end are responsible for the dramatic variations in affinities;
the T at second position of the 3' end of deviates from the
consensus and is severely underrepresented in over 178 bona fide
NF-Y-binding sites (41). Within the -globin promoters, both in human
and in the prosimian G. crassicaudatus, we note that the
third position at the 3' end is the only different nucleotide among the
distal and proximal CCAAT of human and Galago (see Table I),
surprisingly pointing to this position, relatively distant to the core
pentanucleotide, as important in affinity determination.
The bending analysis on the distal and proximal CCAAT gives values that
are very similar, 66° for the distal and 72° for the proximal. This
is not surprising since differences in amplitudes have been shown to be
due to nucleotides flanking the pentanucleotide, which are almost
identical. The circular permutation experiments on the long double
CCAAT oligo show that binding of two NF-Y molecules are compensating in
term of the overall angle, as shown in Fig. 9, with a combined angle of
45°. This value should be reconciled with the fact that the
-globin CCAAT boxes, being separated by 27 bp, lie on opposite sides
of the double helix and that the flexure centers of the two isolated
boxes are identical. Our phasing analysis establishes that NF-Y does
orient DNA upon binding, determining that the overall relative
distortion angles between two NF-Y-bound CCAAT boxes are of about
100°. Since the angle amplitudes are nearly identical, we conclude
that the latter value results from the combination of simultaneous
twisting of the double helix by angles of 40/50° for each of the two
CCAAT boxes; this is in excellent agreement with the value 45°
obtained in the circular permutation assay on double NF-Y binding. Our
assays did not allow us to understand whether the flexures are toward
the major or the minor groove, as might have been inferred from vectors
containing angles with predetermined amplitudes and orientation (41).
It is noteworthy, however, that the NF-Y data obtained here are
remarkably similar in terms of angle amplitudes, bending and twisting,
to core histones bound to DNA in nucleosomal structures, as determined
by crystallographic studies (24). It should be pointed out that the
histone-fold containing NF-Y subunits contact DNA directly and that
this is elicited, in part, through minor groove contacts (14), another feature reminiscent of histones (24). Moreover, recent experiments indicate that NF-Y is able to bind very efficiently to nucleosomal templates.4 Therefore, one
prediction from our studies is that at least part of the NF-Y-CCAAT
interactions will follow rules similar to the ones described for
histone-DNA contacts.
A surprising result of our EMSA is that the C 114 to T
CCAAT mutation, while having a drastic effect on NF-Y binding to the
isolated distal CCAAT (34), is much less crippling in the context of the double CCAAT, indicating that binding of NF-Y to the proximal site
improves distal CCAAT recognition. The opposite is less true. The
equivalent proximal C 87 to T mutation abolishes double
binding almost completely. The "helping" behavior of the proximal
CCAAT could in theory be due to (i) a stabilizing effect of direct
protein-protein interactions or (ii) an indirect effect determined by
DNA distortions (bending and twisting) generated by proximal CCAAT
occupancy. Given the histone-like nature of NF-YB/NF-YC, interactions
among different NF-Y molecules bound to DNA are certainly a
possibility. However, competition experiments are consistent with a
cooperative effect of double binding of NF-Y only for the 5 mutant.
Rather, we favor the second hypothesis; experiments presented by
Jackson et al. (42) suggest that NF-Y binding dramatically
increases the affinity of SREBP-1a for its neighboring target site,
without even forming a stable ternary complex on the DNA. With this
line of reasoning, mutations of the distal CCAAT might alter the
reciprocal interplay between the two NF-Ys, and possibly the
association with additional neighboring factors, rather than the
affinity of NF-Y for the CCAAT sequence per se.
Role of CCAAT Boxes in -Globin Transcription--
The efficient
in vitro transcription system for the -globin promoter
allowed us to determine the role of the CCAAT boxes. Our data are
consistent with the idea that both NF-Y-binding sites contribute to the
optimal activity, and mutations in both CCAAT resulted in transcription
levels that were lower (6-fold) than alterations in either CCAAT alone.
A point mutation in the proximal and removal of the distal CCAAT box
led to a comparable 4-fold decrease in transcription; and swapping an
-like CCAAT box, which is a poor NF-Y-binding site, in the place of
the distal CCAAT weakens the promoter both when the proximal CCAAT
is intact (2-fold) and even more if it is mutated, as in pAG5. Thus,
from the functional point of view, the twin CCAAT boxes seem to have an
additive rather than a multiplicative effect, a result that is in line
with the lack of cooperativity between the two proteins observed in the binding assays. Either CCAAT is nevertheless sufficient to impart rather efficient levels of transcription. This might be entirely due to
strong TATA box and basal elements or to the activity of additional
upstream factors, as suggested by challenging transcription with
anti-GATA antibodies.5
Recent findings by Ronchi et al. (37) with mutated
-globin CCAAT boxes in transgenics suggested that they are important for -globin expression in the adult ( 117 HPFH mutation) but redundant in the embryonic/fetal period; mutations in the distal or in
the proximal sites do not prevent efficient embryonic expression of the
normal -globin gene, a clear indication that additional strong
activators are indeed operating. These findings are in sharp contrast
with the data obtained in another transgenic system; removal of the Y
box from the MHC class II Ea promoter dramatically decreases
transcription, altering start site selection (43). In MHC class II
promoters, NF-Y was shown to help the binding of the neighboring
X-binding proteins, and cooperation between the two
complexes is strictly necessary for efficient activation (29). The less
profound effect of CCAAT mutations observed in the -globin system is
reminiscent of the albumin promoter, in which NF-Y contributes to
in vitro transcription rates by a factor of 3 (12). One
possible explanation for these observations is that complex, highly
efficient promoters, such as globins and albumin, rely on multiple
activators and might be less critically dependent on a single factor,
whereas in the simpler MHC class II system NF-Y plays a more
fundamental role. We favor a scenario in which NF-Y might have distinct
roles depending on the promoter context; in Ea it would directly
participate in the formation of a pre-initiation complex and ultimately
help choosing the start site, in conjunction with an Initiator element
(12, 44); in globin promoters it might help build the overall
architecture and the proper interactions of additional DNA binding
activators.
NF-Y might also have a direct influence on the developmental regulation
of globin promoters; the fact that the -like promoters have among
the most avid NF-Y-binding sites and somewhat simpler promoters
suggests a less refined level of regulation. Recent transgenic
experiments on the human showed that 67 base pairs, including only
the NF-Y-binding CCAAT box and TATA box, are sufficient to direct LacZ
expression in erythroid cells in the correct developmental period (5).
In the -like locus, whose genes are switched on and off three times,
the very low affinity CCAAT boxes of embryonic and adult genes
are most likely not the target of NF-Y. The hemoglobin switching model
based on promoter competition proposed by Grosveld and colleagues (30)
predicts that transcription complexes formed on the differentially
expressed globin promoters play a fundamental role, being alternatively
connected with locus control regions. As a result of the combined CCAAT
bending and twisting, activators binding to the more distal CCAAC,
GATA, and 200 regions might be brought closer to the TATA box and to
the basal transcriptional machinery. Indeed evidence that NF-Y subunits can interact with TATA-binding protein has been recently obtained (45).
Consistent with this hypothesis are two findings, the "stage
selector" element found between the CCAAT and TATA boxes (46) and the
occurrence of several mutations (mostly point mutations) in alleles
associated with persistence of fetal hemoglobin in adults (HPFH). Three
such alterations, HPFH 117, 114, and 13, involve the distal
CCAAT box region. Our results on NF-Y binding to the 114 mutation in
the context of the double CCAAT boxes help explain the apparent
discrepancy of a crippling mutation in a functionally important
element, retaining functional activity; based on the positive effect of
the proximal CCAAT, we anticipate only minor consequences of the 114
for the total effectiveness of the mutant promoter. Nonetheless, HPFH
subtle alterations might alter the fine interplay of factors involved
in the developmental regulation of the gene, by modifying the
bending and twisting of reciprocal angles.
NF-Y Binding to Duplicated CCAAT Boxes--
CCAAT boxes show a
strong position bias within promoters being usually positioned between
60 and 100 (1). Functional experiments indicated that a single
CCAAT box is not able to increase transcription over basal levels, and
multimerized CCAAT boxes also fail to do so. NF-Y can greatly improve
the activity of diverse upstream transcription factors, and in some
cases, it has been proved that it does so by dramatically improving the
affinity of neighboring factors for their target DNA sequence (29, 42). Since no data were available on the binding of NF-Y in promoters harboring more than one CCAAT box, the -globin represents an excellent model to study their relationship. Several findings in our
study bear implications for other systems as follows: (i) bringing two
CCAAT sequences closer than 24 base pairs essentially abrogates double
binding, and (ii) NF-Y complexes are more stable on the DNA only with
the 5 mutant, a deletion bringing the two CCAAT boxes on the same
side of the helix. This suggests that cooperativity is possible,
provided that the correct rotational position is respected. From the
long list of CCAAT-containing promoters activated by NF-Y, a growing
number contains two or more sites (see Table
II); we note that in all, bar the
gp91phox, the distance between the two NF-Y sites is greater
than 27 nucleotides; in three cases, cdc2, H2b, and TK, it is of 30-32
bp, so that the two CCAAT face the same side of the helix. Most
promoters have more distant sites (40/80 bp apart), and it is not known at present whether NF-Y complexes could influence each other at such
distances. The only apparent exception is the gp91phox
promoter, in which two CCAAT boxes are separated by only 14 nucleotides; however, while the proximal CCAAT box has been formally
proven to be a bona fide NF-Y site, the distal CCAAT box appears to
bind NF-Y poorly and is possibly targeted by other proteins. In
conclusion, wherever CCAAT boxes closer than 24 base pairs are found,
binding of NF-Y should be considered as mutually exclusive, or one of them is presumably activated by proteins other than NF-Y. Simultaneous binding of NF-Y to sites with multiples of 10.5 bp might be considered as more stable. Experiments aimed at verifying such hypotheses with our
EMSA systems are currently underway. The assays described here,
binding, bending, and phasing, will also be used in testing the effect
of HPFH mutations in the distal CCAAT region on NF-Y binding.
 |
ACKNOWLEDGEMENT |
We thank L. Cairns for reviewing the
manuscript.
 |
FOOTNOTES |
*
This work was supported in part by grants from Murst (to
R. M. and S. O.), Telethon Grant E596 (to A. R.), EEC Biotec, and from Fondazione Italiana L. Giambrone per la Guarigione della Talassemia.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by Fondazione L. Giambrone.
§
To whom correspondence should be addressed. Tel.:
39-2-26605239/26605225; Fax: 39-2-2664551;
E-mail:mantor{at}imiucca.csi.unimi.it.
1
The abbreviations used are: oligos,
oligonucleotides; HPFH, hereditary persistence of fetal hemoglobin; bp,
base pair(s); EMSA, electrophoretic mobility shift assay; MHC, major
histocompatibility complex; wt, wild type.
2
A. Ronchi, unpublished observations.
3
C. Liberati, S. Ottolenghi, and R. Mantovani,
manuscript in preparation.
4
M. C. Motta and R. Mantovani, manuscript in
preparation.
5
R. Mantovani, unpublished observations.
 |
REFERENCES |
-
Bucher, P.
(1990)
J. Mol. Biol.
212,
563-578[CrossRef][Medline]
[Order article via Infotrieve]
-
Cowie, A.,
and Myers, R. M.
(1988)
Mol. Cell. Biol.
8,
3122-3128[Abstract/Free Full Text]
-
Delvoye, N. L.,
Destroismaisons, N. M.,
and Wall, L. A.
(1993)
Mol. Cell. Biol.
13,
6969-6983[Abstract/Free Full Text]
-
Mason, M. M.,
Grasso, J. A.,
Gavrilova, O.,
and Reitman, M.
(1996)
J. Biol. Chem.
271,
25459-25467[Abstract/Free Full Text]
-
Pondel, M. D.,
Sharpe, J. A.,
Clark, S.,
Pearson, L.,
Wood, W. G.,
and Proudfoot, N. J.
(1996)
Nucleic Acids Res.
24,
4158-4164[Abstract/Free Full Text]
-
Bienz, M.,
and Pelham, H. R. B.
(1986)
Cell
45,
753-760[CrossRef][Medline]
[Order article via Infotrieve]
-
Li-Weber, M.,
Davydov, I. V.,
Krafft, H.,
and Krammer, P. H.
(1994)
J. Immunol.
153,
4122-4133[Abstract]
-
Osawa, H.,
Robey, R. B.,
Printz, R. L,
and Granner, D. K.
(1996)
J. Biol. Chem.
271,
17296-17303[Abstract/Free Full Text]
-
Ruddel, A.
(1995)
Virology
206,
1-7[CrossRef][Medline]
[Order article via Infotrieve]
-
Skalnik, D. G.,
Strauss, E. C.,
and Orkin, S. H.
(1991)
J. Biol. Chem.
266,
16736-167744[Abstract/Free Full Text]
-
Spear, D. H.,
Ericsson, J.,
Jackson, S. M.,
and Edwards, P. A.
(1994)
J. Biol. Chem.
269,
25212-25218[Abstract/Free Full Text]
-
Mantovani, R.,
Pessara, U.,
Tronche, F.,
Li, X. Y.,
Knapp, A. M.,
Pasquali, J. L.,
Benoist, C.,
and Mathis, D.
(1992)
EMBO J.
11,
3315-3322[Medline]
[Order article via Infotrieve]
-
Dorn, A.,
Bollekens, J.,
Staub, A.,
Benoist, C.,
and Mathis, D.
(1987)
Cell
50,
863-872[CrossRef][Medline]
[Order article via Infotrieve]
-
Ronchi, A.,
Bellorini, M.,
Mongelli, N.,
and Mantovani, R.
(1995)
Nucleic Acids Res.
23,
4565-4572[Abstract/Free Full Text]
-
Kim, C. G.,
and Sheffrey, M.
(1990)
J. Biol. Chem.
265,
13362-13369[Abstract/Free Full Text]
-
Sinha, S.,
Maity, S. N.,
Lu, J.,
and de Crombrugghe, B.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
1624-1628[Abstract/Free Full Text]
-
Hahn, S.,
Pinkham, J.,
Weil, R.,
Miller, R.,
and Guarente, L.
(1988)
Mol. Cell. Biol.
8,
655-663[Abstract/Free Full Text]
-
Hooft van Huijsduijnen, R.,
Li, X. Y.,
Black, D.,
Matthes, H.,
Benoist, C.,
and Mathis, D.
(1990)
EMBO J.
9,
3119-3127[Medline]
[Order article via Infotrieve]
-
Li, X.-Y.,
Mantovani, R.,
Hooft van Huijsduijnen, R.,
Andre, I.,
Benoist, C.,
and Mathis, D.
(1992)
Nucleic Acids Res.
20,
1087-1091[Abstract/Free Full Text]
-
McNabb, D. S.,
Xing, Y.,
and Guarente, L.
(1995)
Genes Dev.
9,
47-58[Abstract/Free Full Text]
-
Pinkham, J. L.,
Olesen, S.,
and Guarente, L.
(1987)
Mol. Cell. Biol.
7,
578-585[Abstract/Free Full Text]
-
Bellorini, M.,
Zemzoumi, K.,
Farina, A.,
Berthelsen, J.,
Piaggio, G.,
and Mantovani, R.
(1997)
Gene (Amst.)
193,
119-125[CrossRef][Medline]
[Order article via Infotrieve]
-
Li, X.-Y.,
Hooft van Huijsduijnen, R.,
Mantovani, R.,
Benoist, C.,
and Mathis, D.
(1992)
J. Biol. Chem.
267,
8984-8990[Abstract/Free Full Text]
-
Arents, G.,
and Moudrianakis, E. N.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
10489-10493[Abstract/Free Full Text]
-
Arents, G.,
and Moudrianakis, E. N.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
11170-11174[Abstract/Free Full Text]
-
Xing, Y.,
Fikes, J. D.,
and Guarente, L.
(1993)
EMBO J.
12,
4647-4655[Medline]
[Order article via Infotrieve]
-
Sinha, S.,
Kim, I.-S.,
Sohn, K. Y.,
deCrombrugghe, B.,
and Maity, S. N.
(1996)
Mol. Cell. Biol.
16,
328-337[Abstract]
-
Kim, I.-S.,
Sinha, S.,
deCrombrugghe, B.,
and Maity, S. N.
(1996)
Mol. Cell. Biol.
16,
4003-4013[Abstract]
-
Reith, W.,
Siegrist, C.-A.,
Durand, B.,
Barras, E.,
and Mach, B.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
554-558[Abstract/Free Full Text]
-
Grosveld, F.,
Antoniou, M.,
Berry, M.,
deBoer, E.,
Dillon, N.,
Ellis, J.,
Fraser, P.,
Hurst, A.,
Imam, A.,
Meijer, D.,
Philipsen, S.,
Pruzina, S.,
Stroubulis, J.,
and Whyatt, D.
(1993)
Cold Spring Harbor Symp. Quant. Biol
58,
7-13[Abstract/Free Full Text]
-
Reddy, P. M.,
Stamatoyannopoulos, G.,
Papayannopoulou, T.,
and James Shen, C.-K.
(1994)
J. Biol. Chem.
269,
8287-8295[Abstract/Free Full Text]
-
Mantovani, R.,
Superti-Furga, G.,
Gilman, J.,
and Ottolenghi, S.
(1989)
Nucleic Acids Res.
17,
6681-6691[Abstract/Free Full Text]
-
Superti-Furga, G.,
Barberis, A.,
Schaffner, G.,
and Busslinger, M.
(1988)
EMBO J.
7,
3099-3107[Medline]
[Order article via Infotrieve]
-
Fucharoen, S.,
Shimizu, K.,
and Fukumaki, Y.
(1990)
Nucleic Acids Res.
18,
5245-5253[Abstract/Free Full Text]
-
Berry, M.,
Grosveld, F.,
and Dillon, N.
(1992)
Nature
358,
499-502[CrossRef][Medline]
[Order article via Infotrieve]
-
Ronchi, A.,
Bottardi, S.,
Mazzucchelli, C.,
Ottolenghi, S.,
and Santoro, C.
(1995)
J. Biol. Chem.
270,
21934-21941[Abstract/Free Full Text]
-
Ronchi, A.,
Berry, M.,
Raguz, S.,
Imam, A.,
Yannoutsos, N.,
Ottolenghi, S.,
Grosveld, F.,
and Dillon, N.
(1996)
EMBO J.
15,
143-149[Medline]
[Order article via Infotrieve]
-
Mantovani, R.
(1994)
Methods Mol. Biol.
31,
289-298[Medline]
[Order article via Infotrieve]
-
Mantovani, R.,
Li, X. Y.,
Pessara, U.,
Hooft van Huijsduijnen, R.,
Benoist, C.,
and Mathis, D.
(1994)
J. Biol. Chem.
269,
20340-20346[Abstract/Free Full Text]
-
Kerrpola, T.,
and Curran, T.
(1991)
Cell
66,
316-327
-
Mantovani, R.
(1998)
Nucleic Acids Res.
26,
1135-1143[Abstract/Free Full Text]
-
Jackson, S. M.,
Ericsson, J.,
Mantovani, R.,
and Edwards, P. A.
(1998)
J. Lipid Res.
10,
1-10[Abstract]
-
Benoist, C.,
and Mathis, D.
(1990)
Annu. Rev. Immunol.
8,
681-715[Medline]
[Order article via Infotrieve]
-
Bellorini, M.,
Dantonel, J.-K.,
Yoon, J.-B.,
Roeder, R. G.,
Tora, L.,
and Mantovani, R.
(1996)
Mol. Cell. Biol.
16,
503-512[Abstract]
-
Bellorini, M.,
Lee, D.-K.,
Dantonel, J.-K.,
Zemzoumi, K.,
Roeder, R. G.,
Tora, L.,
and Mantovani, R.
(1997)
Nucleic Acids Res.
25,
2174-2181[Abstract/Free Full Text]
-
Jane, S. M.,
Nienhuis, A.,
and Cunningham, J. M.
(1995)
EMBO J.
14,
97-105[Medline]
[Order article via Infotrieve]
-
Chang, Z. F.,
and Liu, C. J.
(1994)
J. Biol. Chem.
269,
17893-17898[Abstract/Free Full Text]
-
Zwicker, J.,
Lucibello, F. C.,
Wolfraim, L. A.,
Gross, C.,
Truss, M.,
Engeland, K.,
and Muller, R.
(1995)
EMBO J.
14,
4514-4522[Medline]
[Order article via Infotrieve]
-
Zwicker, J.,
Gross, C.,
Lucibello, F. C.,
Truss, M.,
Ehlert, F.,
Engeland, K.,
and Muller, R.
(1995)
Nucleic Acids Res.
23,
3822-3830[Abstract/Free Full Text]
-
Isaacs, R. J.,
Harris, A. L.,
and Hickson, I. D.
(1996)
J. Biol. Chem.
271,
16741-16747[Abstract/Free Full Text]
-
Schweizer-Groyer, G.,
Groyer, A.,
Cadepont, F.,
Grange, T.,
Baulieu, E. E.,
and Pictet, R.
(1994)
Nucleic Acids Res.
22,
1583-1592[Abstract/Free Full Text]
-
Hsiao, K. M.,
McMahon, S. L.,
and Farnham, P. J.
(1994)
Genes Dev.
8,
1526-1537[Abstract/Free Full Text]
-
Barberis, A.,
Superti-Furga, G.,
and Busslinger, M.
(1987)
Cell
50,
347-359[CrossRef][Medline]
[Order article via Infotrieve]
-
Osborne, T. F.,
Gil, G.,
Goldstein, J. L.,
and Brown, N. S.
(1988)
J. Biol. Chem.
263,
3380-3387[Abstract/Free Full Text]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X. Yu, X. Zhu, W. Pi, J. Ling, L. Ko, Y. Takeda, and D. Tuan
The Long Terminal Repeat (LTR) of ERV-9 Human Endogenous Retrovirus Binds to NF-Y in the Assembly of an Active LTR Enhancer Complex NF-Y/MZF1/GATA-2
J. Biol. Chem.,
October 21, 2005;
280(42):
35184 - 35194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Osborne, H. Zhang, G. Fejer, K. M. Palubin, M. I. Niesen, and G. Blanck
Oct-1 Maintains an Intermediate, Stable State of HLA-DRA Promoter Repression in Rb-defective Cells: AN Oct-1-CONTAINING REPRESSOSOME THAT PREVENTS NF-Y BINDING TO THE HLA-DRA PROMOTER
J. Biol. Chem.,
July 9, 2004;
279(28):
28911 - 28919.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Fang, H. Han, G. Stamatoyannopoulos, and Q. Li
Developmentally Specific Role of the CCAAT Box in Regulation of Human {gamma}-Globin Gene Expression
J. Biol. Chem.,
February 13, 2004;
279(7):
5444 - 5449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Coss, S. B. R. Jacobs, C. E. Bender, and P. L. Mellon
A Novel AP-1 Site Is Critical for Maximal Induction of the Follicle-stimulating Hormone {beta} Gene by Gonadotropin-releasing Hormone
J. Biol. Chem.,
January 2, 2004;
279(1):
152 - 162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Salsi, G. Caretti, M. Wasner, W. Reinhard, U. Haugwitz, K. Engeland, and R. Mantovani
Interactions between p300 and Multiple NF-Y Trimers Govern Cyclin B2 Promoter Function
J. Biol. Chem.,
February 21, 2003;
278(9):
6642 - 6650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Gowri, J. H. Yu, A. Shaufl, M. A. Sperling, and R. K. Menon
Recruitment of a Repressosome Complex at the Growth Hormone Receptor Promoter and Its Potential Role in Diabetic Nephropathy
Mol. Cell. Biol.,
February 1, 2003;
23(3):
815 - 825.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Romier, F. Cocchiarella, R. Mantovani, and D. Moras
The NF-YB/NF-YC Structure Gives Insight into DNA Binding and Transcription Regulation by CCAAT Factor NF-Y
J. Biol. Chem.,
January 3, 2003;
278(2):
1336 - 1345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Liberati, M. R. Cera, P. Secco, C. Santoro, R. Mantovani, S. Ottolenghi, and A. Ronchi
Cooperation and Competition between the Binding of COUP-TFII and NF-Y on Human epsilon - and gamma -Globin Gene Promoters
J. Biol. Chem.,
November 2, 2001;
276(45):
41700 - 41709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Duan, G. Stamatoyannopoulos, and Q. Li
Role of NF-Y in In Vivo Regulation of the {gamma}-Globin Gene
Mol. Cell. Biol.,
May 1, 2001;
21(9):
3083 - 3095.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Minuzzo, S. Marchini, M. Broggini, G. Faircloth, M. D'Incalci, and R. Mantovani
Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743
PNAS,
June 6, 2000;
97(12):
6780 - 6784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Caretti, M. C. Motta, and R. Mantovani
NF-Y Associates with H3-H4 Tetramers and Octamers by Multiple Mechanisms
Mol. Cell. Biol.,
December 1, 1999;
19(12):
8591 - 8603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Motta, G. Caretti, G. F. Badaracco, and R. Mantovani
Interactions of the CCAAT-binding Trimer NF-Y with Nucleosomes
J. Biol. Chem.,
January 15, 1999;
274(3):
1326 - 1333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Korner and R. Muller
In Vivo Structure of the Cell Cycle-regulated Human cdc25C Promoter
J. Biol. Chem.,
June 16, 2000;
275(25):
18676 - 18681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Liang, F. Schaufele, and D. G. Gardner
Functional Interaction of NF-Y and Sp1 Is Required for Type A Natriuretic Peptide Receptor Gene Transcription
J. Biol. Chem.,
January 5, 2001;
276(2):
1516 - 1522.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|